Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Solar still on the rise, Ecotricity says
Markets

Solar still on the rise, Ecotricity says

Commercial solar generation is up almost 300%.

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025